With any kind of luck, chemotherapy’s days as one of the leading cancer treatments will be over soon. A new, revolutionary therapy is on the horizon. Researchers have announced that this breakthrough treatment would utilize the body’s own immune system to attack cancer cells — a huge improvement over toxic chemo.
Natural News reports that scientists from the Memorial Sloan Kettering Cancer Center, located in New York, claim to have successfully experimented with the new treatment. Sixteen people with advanced leukemia that had run out of alternatives volunteered to be part of their experiment and underwent what the researchers have dubbed “targeted T cell therapy.” Miraculously, the therapy actually eliminated cancerous cells in most of the patients.
Dr David Agus, a CBS News expert contributor who leads the Westside Cancer Center at the University of Southern California has called the team’s work “remarkable.”
The study’s senior author, Dr Renier Brentjens, an oncologist at Memorial Sloan Kettering, is very confident about their findings and hopeful for the future. Dr Brentjens told HealthDay News, “ First and foremost, we’ve shown that this isn’t a fluke. This is a reliable result.” Though he notes that the research is budding, he believes that it is quite a promising beginning.
Of the 16 patients who participated in the study, 14 were able to reach total remission. Aggressive leukemia is known for coming back if patients do not undergo a bone marrow transplant. Unfortunately, patients cannot undergo the transplant until the cancer cells have been eliminated from their bloodstream.
However, the new targeted T cell therapy yielded amazing results and most of the patients saw their blood become cancer-free, allowing them to finally undergo bone marrow transplants. After receiving a transplant, patients can actually be cured of the disease.